Author Question: For an employer, which of the following is NOT an advantage of telecommuting? A) higher ... (Read 22 times)

elizabeth18

  • Hero Member
  • *****
  • Posts: 559
For an employer, which of the following is NOT an advantage of telecommuting?
 
  A) higher productivity
  B) reduced absences
  C) retention of valuable employees
  D) coordination of work

Question 2

Employees who telecommute ________ when compared to employees who do not telecommute.
 
  A) are less satisfied with their supervisors
  B) experience higher levels of role conflict and ambiguity
  C) are less satisfied with their opportunities for promotion
  D) profess lower levels of organizational commitment



harveenkau8139

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library